Jiangsu Wanbang Biopharmaceuticals
E1370262
UNEXPLORED
Jiangsu Wanbang Biopharmaceuticals is a Chinese pharmaceutical company known for developing and manufacturing drugs, particularly in areas such as endocrinology and chronic disease treatment.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Jiangsu Wanbang Biopharmaceuticals canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T19331800 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Jiangsu Wanbang Biopharmaceuticals Context triple: [Fosun Pharma, hasSubsidiary, Jiangsu Wanbang Biopharmaceuticals]
-
A.
Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
B.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
C.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
D.
Shanghai Jiushi Group
Shanghai Jiushi Group is a major state-owned enterprise in Shanghai involved in urban infrastructure, transportation, and sports and cultural event operations.
-
E.
Jianghuai Guanhua
Jianghuai Guanhua is a major variety of Mandarin Chinese spoken primarily in parts of Jiangsu and Anhui provinces, characterized by distinctive phonological and lexical features.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Jiangsu Wanbang Biopharmaceuticals Target entity description: Jiangsu Wanbang Biopharmaceuticals is a Chinese pharmaceutical company known for developing and manufacturing drugs, particularly in areas such as endocrinology and chronic disease treatment.
-
A.
Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
B.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
C.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
D.
Shanghai Jiushi Group
Shanghai Jiushi Group is a major state-owned enterprise in Shanghai involved in urban infrastructure, transportation, and sports and cultural event operations.
-
E.
Jianghuai Guanhua
Jianghuai Guanhua is a major variety of Mandarin Chinese spoken primarily in parts of Jiangsu and Anhui provinces, characterized by distinctive phonological and lexical features.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.